459 related articles for article (PubMed ID: 33933604)
1. Alleviation of neurological disease by RNA editing.
Zhang S; Chen L; Zhang Y; Fang D
Methods; 2021 Oct; 194():94-99. PubMed ID: 33933604
[TBL] [Abstract][Full Text] [Related]
2. Insights Gained from RNA Editing Targeted by the CRISPR-Cas13 Family.
Liu L; Pei DS
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232699
[TBL] [Abstract][Full Text] [Related]
3. Applications of CRISPR/Cas13-Based RNA Editing in Plants.
Kavuri NR; Ramasamy M; Qi Y; Mandadi K
Cells; 2022 Aug; 11(17):. PubMed ID: 36078073
[TBL] [Abstract][Full Text] [Related]
4. Molecular Mechanisms of RNA Targeting by Cas13-containing Type VI CRISPR-Cas Systems.
O'Connell MR
J Mol Biol; 2019 Jan; 431(1):66-87. PubMed ID: 29940185
[TBL] [Abstract][Full Text] [Related]
5. CRISPR-Based Technologies: Impact of RNA-Targeting Systems.
Terns MP
Mol Cell; 2018 Nov; 72(3):404-412. PubMed ID: 30388409
[TBL] [Abstract][Full Text] [Related]
6. Applications of the versatile CRISPR-Cas13 RNA targeting system.
Kordyś M; Sen R; Warkocki Z
Wiley Interdiscip Rev RNA; 2022 May; 13(3):e1694. PubMed ID: 34553495
[TBL] [Abstract][Full Text] [Related]
7. Optimization of specific RNA knockdown in mammalian cells with CRISPR-Cas13.
Burris BJD; Molina Vargas AM; Park BJ; O'Connell MR
Methods; 2022 Oct; 206():58-68. PubMed ID: 35987443
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of Engineered CRISPR-Cas-Mediated Systems for Site-Specific RNA Editing.
Marina RJ; Brannan KW; Dong KD; Yee BA; Yeo GW
Cell Rep; 2020 Nov; 33(5):108350. PubMed ID: 33147453
[TBL] [Abstract][Full Text] [Related]
9. Assessing and advancing the safety of CRISPR-Cas tools: from DNA to RNA editing.
Tao J; Bauer DE; Chiarle R
Nat Commun; 2023 Jan; 14(1):212. PubMed ID: 36639728
[TBL] [Abstract][Full Text] [Related]
10. CASowary: CRISPR-Cas13 guide RNA predictor for transcript depletion.
Krohannon A; Srivastava M; Rauch S; Srivastava R; Dickinson BC; Janga SC
BMC Genomics; 2022 Mar; 23(1):172. PubMed ID: 35236300
[TBL] [Abstract][Full Text] [Related]
11. Programmable RNA targeting with CRISPR-Cas13.
Shi P; Wu X
RNA Biol; 2024 Jan; 21(1):1-9. PubMed ID: 38764173
[TBL] [Abstract][Full Text] [Related]
12. CRISPR-Cas13 technology portfolio and alliance with other genetic tools.
Wu S; Tian P; Tan T
Biotechnol Adv; 2022 Dec; 61():108047. PubMed ID: 36208845
[TBL] [Abstract][Full Text] [Related]
13. CRISPR guides induce gene silencing in plants in the absence of Cas.
Sharma VK; Marla S; Zheng W; Mishra D; Huang J; Zhang W; Morris GP; Cook DE
Genome Biol; 2022 Jan; 23(1):6. PubMed ID: 34980227
[TBL] [Abstract][Full Text] [Related]
14. Advances in CRISPR-Cas systems for RNA targeting, tracking and editing.
Wang F; Wang L; Zou X; Duan S; Li Z; Deng Z; Luo J; Lee SY; Chen S
Biotechnol Adv; 2019; 37(5):708-729. PubMed ID: 30926472
[TBL] [Abstract][Full Text] [Related]
15. Functional Features and Current Applications of the RNA-Targeting Type VI CRISPR-Cas Systems.
Perčulija V; Lin J; Zhang B; Ouyang S
Adv Sci (Weinh); 2021 Jul; 8(13):2004685. PubMed ID: 34254038
[TBL] [Abstract][Full Text] [Related]
16. Utility of Self-Destructing CRISPR/Cas Constructs for Targeted Gene Editing in the Retina.
Li F; Hung SSC; Mohd Khalid MKN; Wang JH; Chrysostomou V; Wong VHY; Singh V; Wing K; Tu L; Bender JA; Pébay A; King AE; Cook AL; Wong RCB; Bui BV; Hewitt AW; Liu GS
Hum Gene Ther; 2019 Nov; 30(11):1349-1360. PubMed ID: 31373227
[TBL] [Abstract][Full Text] [Related]
17. [Advances in the RNA-targeting CRISPR-Cas systems].
Hong T; Luo Q
Sheng Wu Gong Cheng Xue Bao; 2023 Apr; 39(4):1363-1373. PubMed ID: 37154311
[TBL] [Abstract][Full Text] [Related]
18. Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications.
Siew WS; Tang YQ; Kong CK; Goh BH; Zacchigna S; Dua K; Chellappan DK; Duangjai A; Saokaew S; Phisalprapa P; Yap WH
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445123
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Cas13 Inhibitors Block RNA Editing in Bacteria and Mammalian Cells.
Lin P; Qin S; Pu Q; Wang Z; Wu Q; Gao P; Schettler J; Guo K; Li R; Li G; Huang C; Wei Y; Gao GF; Jiang J; Wu M
Mol Cell; 2020 Jun; 78(5):850-861.e5. PubMed ID: 32348779
[TBL] [Abstract][Full Text] [Related]
20. Programmable RNA base editing with photoactivatable CRISPR-Cas13.
Yu J; Shin J; Yu J; Kim J; Yu D; Heo WD
Nat Commun; 2024 Jan; 15(1):673. PubMed ID: 38253589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
